# Aligos Therapeutics, Inc.: Form 8-K, filed Aug 4, 2022

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2022-08-04
- Accepted by EDGAR: Aug 4, 2022, 16:06 ET
- Period: 2022-08-04
- Accession: 0001171843-22-005357
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000117184322005357/f8k_080322.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000117184322005357/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000117184322005357/f8k_080322.htm

Filed Aug 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001171843-22-005357. Last ingested by Listed: Nov 6, 2026, 12:13 ET. No prices; not investment advice.